Delivery Order SPE2DB20D1100-SPE2DB25FD0P9
Award Date
6/24/25
Potential Completion Date
6/25/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,576.64, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML medical supplies. The award is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order for the pharmaceutical product EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML. The $6,379.26 Firm Fixed Price contract is funded by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support. The contract has an ultimate completion date of June 18, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,030.20 firm fixed-price delivery order is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for joint pain treatment. The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML medical supplies. The single-award, Firm Fixed Price Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $2,205.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a performance period through May 6, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a firm fixed price of $13,608.96 and a completion date of September 5, 2024. This award is not set aside for a specific business type. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,906.69 delivery order contract is for the supply of Euflexxa 20 mg/2 ml syringes. The contract has an ultimate completion date of March 5, 2024 and is a firm fixed-price type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $14,252.64, is for the delivery of EUFLEXXA 20 MG/2 ML syringes to support military treatment programs and facilities. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,566.49, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a period of performance through June 12, 2025. The contract is a Firm Fixed Price (FFP) delivery order with no set-aside designation, indicating open competition....
This federal contract award, valued at $2,793.03, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...